Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0050728; negative regulation of inflammatory response | 5.250E-09 | 2.858E-05 | FFAR4, NFKB1, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0015908; fatty acid transport | 6.408E-08 | 1.073E-04 | FABP3, PPARA, PPARD, PPARG |
BP | GO:0051179; localization | GO:0010891; negative regulation of sequestering of triglyceride | 3.534E-06 | 2.138E-03 | PPARA, PPARG |
BP | GO:0051179; localization | GO:0010887; negative regulation of cholesterol storage | 5.300E-06 | 2.626E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:0010871; negative regulation of receptor biosynthetic process | 5.300E-06 | 2.626E-03 | PPARA, PPARG |
BP | GO:0008152; metabolic process | GO:2001300; lipoxin metabolic process | 5.300E-06 | 2.626E-03 | ALOX15, HPGD |
BP | GO:0050896; response to stimulus | GO:0042060; wound healing | 1.306E-05 | 4.819E-03 | ALOX15, PPARA, PPARD |
BP | GO:0050896; response to stimulus | GO:0070542; response to fatty acid | 1.465E-05 | 5.251E-03 | FABP3, FFAR1, PPARG |
BP | GO:0008152; metabolic process | GO:1902894; negative regulation of pri-miRNA transcription from RNA polymerase II promoter | 1.940E-05 | 5.949E-03 | PPARA, PPARD |
BP | GO:0051179; localization | GO:0060099; regulation of phagocytosis, engulfment | 1.940E-05 | 5.949E-03 | ALOX15, PPARG |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa03320 | PPAR signaling pathway_Homo sapiens_hsa03320 | 6.289E-08 | 4.402E-06 | FABP3; PPARG; PPARA; PPARD |
hsa04024 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.998E-04 | 4.662E-03 | PPARA; NFKB1; TSHR |
hsa04210 | Apoptosis_Homo sapiens_hsa04210 | 3.067E-03 | 1.952E-02 | LMNA; NFKB1 |
hsa04211 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.399E-03 | 1.495E-02 | PPARG; NFKB1 |
hsa04380 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.732E-03 | 1.941E-02 | PPARG; NFKB1 |
hsa04920 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 7.791E-04 | 1.091E-02 | PPARA; NFKB1 |
hsa04931 | Insulin resistance_Homo sapiens_hsa04931 | 1.874E-03 | 1.640E-02 | PPARA; NFKB1 |
hsa04932 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 3.556E-03 | 2.075E-02 | PPARA; NFKB1 |
hsa05016 | Huntington's disease_Homo sapiens_hsa05016 | 5.737E-03 | 3.089E-02 | HTT; PPARG |
hsa05160 | Hepatitis C_Homo sapiens_hsa05160 | 2.773E-03 | 1.941E-02 | PPARA; NFKB1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
C00-D49: Neoplasms | Thyroid cancer | C73 | TSHR |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1 |
C00-D49: Neoplasms | Thyroid cancer diagnosis | C73 | TSHR |
E00-E89: Endocrine, nutritional and metabolic diseases | Obesity | E66 | PPARD; PPARD; PPARG |
E00-E89: Endocrine, nutritional and metabolic diseases | Hyperlipidaemia | E78 | PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases | Non-insulin dependent diabetes | E11.9 | FFAR1 |
E00-E89: Endocrine, nutritional and metabolic diseases | Metabolic disorders | E70-E89 | PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases | Dyslipidaemias | E78 | PPARD; PPARD |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | FFAR1; PPARG |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | FFAR1; PPARD; PPARG; PPARG; NFKB1 |